The KLK3 gene makes prostate specific antigen, a protein released by the prostate that helps semen become more fluid after ejaculation. If it does not work properly, semen may stay thicker than usual, which can affect sperm movement and fertility. Some people first learn about this gene when a PSA blood test is discussed, because KLK3 influences PSA levels used to help assess prostate health. KLK3 became well known through the broad public debate over PSA screening for prostate cancer.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate what happens in the body. Some genes provide the directions for proteins, which do much of the cell’s work. Others mainly guide when, where, and how much certain activities take place. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, and medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
KLK3Gene function
What if the gene works
The KLK3 gene helps the prostate make PSA, a protein released into semen. PSA helps semen stay liquid after ejaculation, which supports sperm movement.
Risk
What if the gene does not work
Changes in the KLK3 gene can range from milder to more severe variants and may reduce or alter prostate specific antigen activity. This can affect how seminal fluid liquefies and how this protein interacts with other proteins in prostate secretions.
Treatment
What does that mean for your treatment
No KLK3-specific treatment or drug choice is currently established for people with a pathogenic or loss-of-function variant in the KLK3 gene. In practice, the KLK3 gene is used mainly as a biomarker in prostate cancer care, rather than as a guide to choosing medicines based on inherited KLK3 variants.
Gene function
What if the gene works
In the prostate, the KLK3 gene makes a protein called PSA that is released into semen. Its main job is to help semen become more fluid after ejaculation. That change supports sperm movement through the reproductive tract. This core KLK3 gene function in the prostate supports normal fertility.
The KLK3 gene provides instructions for PSA, an enzyme (a protein that cuts other proteins) released by the prostate. This protein cutting helps start the normal change of semen from a thick gel to a more fluid liquid.
After ejaculation, PSA breaks down semen-forming proteins that first make semen thick. This normal thinning process, called liquefaction, helps semen spread and move more easily.
By making semen less thick, PSA helps create conditions that support sperm movement. This allows sperm to move more freely through the reproductive tract after release.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants have no noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes a gene’s function more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
KLK3 gene variants can change how much PSA a cell makes or alter the PSA protein so it folds less well, is less stable, or has lower enzyme activity after it is released. This is how KLK3 gene variants affect PSA production and function at a molecular level. Milder variants may cause small shifts in protein levels or activity, while more severe variants can more strongly disrupt processing, secretion, or the protein’s active site.
How variants are linked to conditions
Variants in the KLK3 gene are linked mainly to prostate cancer risk and to differences in prostate specific antigen (PSA) blood levels. Research on KLK3 gene variants and prostate cancer risk shows small shifts in susceptibility rather than a clear diagnosis on their own. These changes may also affect how PSA screening results look, which can influence how prostate findings are interpreted.
A variant is not necessarily a diagnosis
Variants in genes are a routine part of human biology and are widespread in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a certain diagnosis, especially when multiple genes and environmental factors play a role. In other cases, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that clearly increase or reduce health risk directly because of changes in the KLK3 gene. Some inherited changes may slightly affect prostate cancer risk or PSA blood test levels, but age, family history, ancestry, and overall prostate health still play a much bigger role for most people.
Inheritance of KLK3 variants
There is not yet a broadly confirmed Mendelian inheritance pattern tied to a specific KLK3 related condition, so how KLK3 gene variants are inherited in a disease causing sense is not defined in the same way as for genes linked to a clear dominant or recessive condition. Most reported KLK3 findings are discussed as risk influencing variants rather than variants that by themselves establish a diagnosis. The KLK3 gene is located on chromosome 19, which is an autosome, so you inherit one copy from each parent. That means a KLK3 variant, if present, can be passed from either mother or father to a child.
What does my KLK3 result mean for my family?
There is not a broadly confirmed inherited pattern linking KLK3 to a specific single-gene condition in families, though this can change as research grows. If you have a KLK3 result and want to understand what it could mean for close relatives, a doctor or genetic counselor can explain it in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
To understand how genetic testing for KLK3 variants works, a lab analyzes DNA from a blood or saliva sample and reads the KLK3 gene for inherited changes. Results may show a known variant, no significant variant, or a finding that needs more interpretation, and they are not usually enough on their own to diagnose disease.
When should I consider getting a genetic test?
There is not yet a broadly established reason to have genetic testing just for the KLK3 gene. Decisions about genetic testing are usually based on your personal and family history of prostate cancer and are best made with a doctor or genetic counselor.
A genetic result is only one part of your health story
Genetic test results can be informative, yet how much they explain varies depending on the condition and the specific type of variant. Many other factors also shape how the body works over time, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when viewed together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, how strongly it acts, or how sensitive someone is to side effects. This helps explain why the same treatment works well for one person, has little effect in another, or causes more unwanted effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can shape their response to medications. It focuses on gene and drug patterns to help explain why the same treatment may work differently in different people. For many medicines, genes influence either how strongly a drug works or how the body handles it. This information can support treatment choices that are more informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the KLK3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so general questions about medicines, side effects, or your health are best discussed with your doctor. KLK3 is studied more for its link to prostate-specific antigen, a blood marker used in prostate care, than for clear, routine drug-response decisions.
History
The KLK3 gene became widely recognized through the history of PSA, a lab marker that changed how prostate health was discussed in clinics and public life. In recent decades, awareness of this gene’s role has grown as PSA testing became common in screening and follow-up care. Researchers identified PSA in the 1970s and 1980s, and later linked it to the KLK3 gene within a cluster of related kallikrein genes on chromosome 19. Scientific classifications changed as researchers learned more about the gene, and PSA was eventually understood as the protein product of the KLK3 gene. As PSA testing spread in the 1990s, the gene entered broader medical conversations about early detection, overdiagnosis, and shared decision-making. These historical steps shaped today’s understanding.